Next Generation News and Research

RSS

Ventana, CST enter license agreement for personalized cancer diagnostics

Cell Signaling Technology, Inc. of Danvers, MA, announced today that it has granted Ventana Medical Systems, Inc., a worldwide non-exclusive license to CST patent rights and proprietary antibody reagents relating to the detection of epidermal growth factor receptor mutations for the field of tissue-based in vitro diagnostic testing.

From Cell Signaling Technology 16 Mar 2011

Genomatix launches service model for NGS data analysis

The growing amount of data created by today's high throughput DNA sequencing technology presents a major challenge to scientists around the globe. How to handle the staggering amount of data, and, more importantly, how to answer the biological questions that initiated the experiment?

16 Mar 2011

Ingenuity announces new features to support RNA-Seq workflows, microRNA research in IPA

Ingenuity Systems, a leading provider of information and analytics solutions for life science researchers, today announced new features to support RNA-Sequencing workflows and microRNA research in IPA.

15 Mar 2011

Cancer Research UK introduces new centre in Oxford

A new centre launched today will cement Oxford's place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country.

15 Mar 2011

WaferGen Biosystems 2010 revenue exceeds guidance

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the three months and year ended December 31, 2010.

14 Mar 2011

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.

14 Mar 2011

New analytic method suggests tumors grow in punctuated, staccato-like bursts

A new method of analyzing cancerous tumors developed by scientists at Cold Spring Harbor Laboratory suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like bursts.

14 Mar 2011

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.

11 Mar 2011

Murad launches new powerhouse anti-aging treatment product

Murad, Inc. has announced the launch of Complete Reform with Glyco Firming Complex, the latest powerhouse anti-aging treatment product in the company's award-winning Age Reform line.

11 Mar 2011

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

California Institute of Technology graduate student Guoan Zheng is the recipient of the 2011 $30,000 Lemelson-MIT Caltech Student Prize.

10 Mar 2011

Solazyme executes JDA and LOI with DOW to advance algal technology

Solazyme, Inc., a leading renewable oils and bioproducts company, announced today the execution of both a joint development agreement and a letter of intent with The Dow Chemical Company to advance the development of Solazyme's algal oils for use in next generation, bio-based dielectric insulating fluids key to transformers and other electrical applications.

10 Mar 2011

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

RainDance Technologies, Inc., and 454 Life Sciences, a Roche Company, today announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the simple and cost-effective investigation of drug absorption, distribution, metabolism, and excretion (ADME).

9 Mar 2011

Geospiza, NuGEN partner to develop seamless next-generation sequencing workflow

Geospiza, Inc., the market leading developer of genetic analysis software, and NuGEN Technologies, Inc., the leader in sample preparation solutions for clinical samples, today announced a co-marketing agreement to develop a seamless next-generation sequencing workflow to accelerate discoveries for large disease research studies.

9 Mar 2011

Postdoctoral research fellows receive Pancan- AACR Pathway to Leadership Grants

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Jennifer M. Bailey, Ph.D., and E. Scott Seeley, M.D., Ph.D., the 2011 Pancreatic Cancer Action Network - AACR Pathway to Leadership Grants.

9 Mar 2011

Next Generation Identification System to process fingerprint transactions more effectively

New technology designed to revolutionize law enforcement's ability to process fingerprints has reached its initial operating capability, the FBI announced today.

9 Mar 2011

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

After a thorough head-to-head evaluation against various competing solutions, the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute has selected CLC bio's enterprise platform for next generation sequence analysis.

8 Mar 2011

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion genetic screening panel for use on next-generation sequencing systems.

8 Mar 2011

Leading advocacy organizations to mark International Women's Day with panel discussion

Leading advocacy organizations American Jewish World Service, Women Thrive Worldwide and the Modernizing Foreign Assistance Network will mark International Women's Day, on March 8 at 8:30 a.m. with a breakfast and panel discussion highlighting the importance of women to a more effective, accountable, and results-oriented U.S. approach to promoting development in poor countries.

5 Mar 2011

Next Generation News and Research

Ventana, CST enter license agreement for personalized cancer diagnostics

Genomatix launches service model for NGS data analysis

Ingenuity announces new features to support RNA-Seq workflows, microRNA research in IPA

Cancer Research UK introduces new centre in Oxford

WaferGen Biosystems 2010 revenue exceeds guidance

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

New analytic method suggests tumors grow in punctuated, staccato-like bursts

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

Murad launches new powerhouse anti-aging treatment product

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

Solazyme executes JDA and LOI with DOW to advance algal technology

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

Geospiza, NuGEN partner to develop seamless next-generation sequencing workflow

Postdoctoral research fellows receive Pancan- AACR Pathway to Leadership Grants

Next Generation Identification System to process fingerprint transactions more effectively

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

Leading advocacy organizations to mark International Women's Day with panel discussion

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News